References
- Kageyama R, Ohkubo H, Nakanishi S. Induction of rat liver angiotensinogen mRNA following acute inflammation. Biochem Biophys Res Commun 1985; 129: 3, 826–32
- Hidaka H, Itoh S, Sato R, Oda T. New direct radioimmunoassay for human renin substrate and heterogeneity of human renin substrate in pathological states. Jap Circ J 1 9811; 44: 375–83
- Genain C, Bouhnik J, Tewksbury D, Corvol P, Menard J. Characterization of plasma and cerebrospinal fluid human angiotensinogen and desangiotensin 1-angiotcnsinogen by direct radioimmunoassay. J Clin Endocrinol Metab 1984; 59: 478–84
- Sato Y, Hiwada K, Kokubu T. Direct radioimmunoassay for human renin substrate and its measurement in plasma from essential hypertensive patients diabetic patients and pregnant women. Jap Circ J 1984; 48: 1236–42
- Gould A B, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 1971; 5: 86–9
- Helmer O M, Griffith R S. The effect of the administration of estrogens on the renin substrate content of rat plasma. Endocrinology 1952; 51: 421–6
- Hasegawa H, Nasjletti A, Rice K, Masson G MC. Role of pituitary and adrenals in the regulation of plasma angiotensinogen. Am J Physiol 1973; 225: 1–6
- Dzau V J, Herrmann H C. Hormonal control of angiotensinogen production. Life Sci 1982; 30: 577–84
- Carretero O, Gross F. Renin substrate in plasma under various experimental conditions in the rat. Am J Physiol 1967; 213: 695–700
- Blair-West J R, Reid I A, Ganong W F. Stimulation of angiotensinogen release by raised blood angiotensin concentration in the dog. Clin Sci Mol Med 1974; 46: 665–9
- Khayyall M, McGregor J, Brown J J, Lever A F, Robertson J IS. Increase in plasma renin substrate concentration after infusion of angiotensin in the rat. Clin Sci 1973; 44: 87–90
- Genain C, Aldigier J C, Guyenne I T, Corvol P. Menard J. Direct radioimmunoassays of renin and renin substrate during converting enzyme inhibition. Clin Exp Hypertens—Theory and Practice 1982; A4(11 and 12)2193–202
- Rasmussen S, Damkjaer Nielsen M, Giese J. Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays. Clin Sci 1981; 60: 591–3
- Fyhrquist F. Discussion remark. Angiotensin Converting Enzyme Inhibitors, Mechanisms of Action and Clinical Implications, Z P Horowitz. Urban & Schwarzenherg, Baltimore, Munich 1981; 99
- Radziwill R, Stutzmann M, Hilgenfeldt U, Hackenthal E. Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat. European J Pharmacol 1986; 122: 59–64
- Rosenlöf K. Immunological comparison of renin substrate with erythropoietin. Scand J Clin Lab Invest 1986; 46: 497–504
- Tewksbury D A. Angiotensinogen. Fed Proc 1983; 42: 2724–8
- Haas E, Goldblatt H, Gipson E C, LaVera L. Extraction purification and assay of human renin free of angiotensinase. Circ Res 1966; 19: 739–49
- Immonen I, Fyhrquist F, Pohjavuori M, Simell O. Age dependence of human plasma renin substrate. Scand J Clin Lab Invest 1981; 41: 167–70
- Soveri P. Renin in Human Pregnancy and During Oral Contraception. University of Helsinki, Finland 1978; 60, Academic dissertation
- Greenwood F C, Hunter W, Glover J S. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–23
- Fyhrquist F, Soveri P, Puutula L. Stenman U-H. Radioimmunoassay of plasma renin activity. Clin Chcm 1976; 22: 25, 6
- Millar J A, Derckx F HM, McLean K, Reid J L. Pharmacodynamics of converting enzyme inhibition: the cardiovascular endocrine and autonomic effects of MK-421 and MK-521. Br J Clin Pharmacol 1984; 17: 347–55
- Clauser E, Bouhnik J, Gonzalez M F, Corvol P, Menard J. Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen. Am J Physiol 1984; 246: E129–E133, Endocrinol Metab 9